Trulieve Cannabis is trading 4.22% lower at $12.01 as broader U.S. market weakness pressured risk assets on September 24, 2026.

  • The S&P 500, Nasdaq Composite, and Dow Jones were all down more than 0.5%.
  • Elevated Treasury yields and inflation concerns are weighing on growth-oriented equities.
  • The September 22 index-inclusion announcement had supported a sharp rally, but no fresh company-specific catalyst was identified for September 24.